CHAPEL HILL, N.C., Sep 12, 2003 (BUSINESS WIRE) -- POZEN Inc.
(NASDAQ: POZN) announced today that POZEN will be presenting to
investors at two upcoming conferences.
Matthew E. Czajkowski the company's chief financial officer, will
be speaking at the ThinkEquity Growth Conference on Wednesday,
September 17, at 10:30 a.m. Eastern Time.
John R. Plachetka, Pharm.D., the company's chairman, president and
chief executive officer, will be speaking to investors at the UBS
Global Life Sciences Conference on Wednesday, September 24, at 8:30
a.m. Eastern Time. Dr. Plachetka's presentation will be webcast
live and archived on POZEN's home page at www.pozen.com.
POZEN is a pharmaceutical company developing therapeutic
advancements in a cost effective manner. Product development efforts
are focused on diseases with unmet medical needs where POZEN can
improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has developed the largest and most advanced product
pipeline in the field of migraine. POZEN has development and
commercial alliances with GlaxoSmithKline, Xcel, and Nycomed. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
Chief Financial Officer
Director, Investor Relations